Jc Bioage Analytical Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 15-12-2024
- Paid Up Capital ₹ 2.50 M
as on 15-12-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 15.34%
(FY 2020)
- Profit -76.54%
(FY 2020)
- Ebitda -55.94%
(FY 2020)
- Net Worth 7.15%
(FY 2020)
- Total Assets -9.09%
(FY 2020)
About Jc Bioage Analytical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nileshkumar Patel and Jayati Chakraborty serve as directors at the Company.
- CIN/LLPIN
U24100TG2014PTC092466
- Company No.
092466
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jc Bioage Analytical Private Limited offer?
Jc Bioage Analytical Private Limited offers a wide range of products and services, including Testing & Measuring Equipments, Food Testing Equipment, Measuring Equipments & Instruments, Measurement Instrument, Laboratory Testing Equipment.
Who are the key members and board of directors at Jc Bioage Analytical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nileshkumar Patel  | Director | 22-Jan-2014 | Current |
| Jayati Chakraborty | Director | 22-Jan-2014 | Current |
Financial Performance of Jc Bioage Analytical.
Jc Bioage Analytical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 15.34% increase. The company also saw a substantial fall in profitability, with a 76.54% decrease in profit. The company's net worth moved up by a moderate rise of 7.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jc Bioage Analytical?
In 2018, Jc Bioage Analytical had a promoter holding of 62.67% and a public holding of 37.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jc Bioage Analytical?
Unlock and access historical data on people associated with Jc Bioage Analytical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jc Bioage Analytical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jc Bioage Analytical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
